As of 2026-09-20, the EV/EBITDA ratio of Surgery Partners Inc (SGRY) is -30.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SGRY's latest enterprise value is 5,267.47 mil USD. SGRY's TTM EBITDA according to its financial statements is -175.10 mil USD. Dividing these 2 quantities gives us the above SGRY EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 13.2x | 10.4x |
| Forward P/E multiples | 10.0x - 11.2x | 10.8x |
| Fair Price | (35.78) - 12.90 | (14.58) |
| Upside | -370.0% - -2.6% | -210.0% |
| Date | EV/EBITDA |
| 2026-09-18 | -30.08 |
| 2026-09-17 | -30.16 |
| 2026-09-16 | -30.59 |
| 2026-09-15 | -30.38 |
| 2026-09-14 | -30.67 |
| 2026-09-11 | -30.93 |
| 2026-09-10 | -30.73 |
| 2026-09-09 | -30.73 |
| 2026-09-08 | -30.61 |
| 2026-09-04 | -30.84 |
| 2026-09-03 | -30.77 |
| 2026-09-02 | -30.63 |
| 2026-09-01 | -31.09 |
| 2026-08-31 | -30.56 |
| 2026-08-28 | -30.41 |
| 2026-08-27 | -30.59 |
| 2026-08-26 | -30.67 |
| 2026-08-25 | -30.68 |
| 2026-08-24 | -30.61 |
| 2026-08-21 | -31.03 |
| 2026-08-20 | -30.60 |
| 2026-08-19 | -30.34 |
| 2026-08-18 | -30.82 |
| 2026-08-17 | -30.91 |
| 2026-08-14 | -31.41 |
| 2026-08-13 | -31.53 |
| 2026-08-12 | -31.63 |
| 2026-08-11 | -31.39 |
| 2026-08-10 | -32.10 |
| 2026-08-07 | -31.79 |
| 2026-08-06 | -31.33 |
| 2026-08-05 | -31.63 |
| 2026-08-04 | -31.88 |
| 2026-08-03 | -32.18 |
| 2026-07-31 | -31.69 |
| 2026-07-30 | -32.06 |
| 2026-07-29 | -32.44 |
| 2026-07-28 | -31.82 |
| 2026-07-27 | -31.52 |
| 2026-07-24 | -31.94 |
| 2026-07-23 | -31.55 |
| 2026-07-22 | -31.50 |
| 2026-07-21 | -32.36 |
| 2026-07-20 | -32.16 |
| 2026-07-17 | -32.13 |
| 2026-07-16 | -32.61 |
| 2026-07-15 | -32.05 |
| 2026-07-14 | -31.48 |
| 2026-07-13 | -32.12 |
| 2026-07-10 | -32.44 |